Balloon Assisted Transarterial Therapy for Hepatocellular Carcinoma

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

The balloon catheter is placed at the various arterial feeders of the tumor

use of a balloon catheter for providing balloon occlusion, in addition to the standard microcatheter for drug delivery, both catheters are to be placed in parallel through a single guide catheter. Only one arterial puncture wound is involved. The inflated balloon provides temporary occlusion of all arterial tumor feeders except for the one which is selectively catheterized with a microcatheter for delivery of the therapeutic agent. The therapeutic agent consists of Lipiodol mixed with a chemotherapeutic drug, it is delivered through the microcatheter under fluoroscopic control.

Trial Locations (1)

Unknown

Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER